Groupe Hospitalier Universitaire, APHP Site Saint-Louis- Université de Paris, Oncologie-Radiothérapie, Paris, France.
Radiother Oncol. 2021 Apr;157:163-174. doi: 10.1016/j.radonc.2021.01.009. Epub 2021 Jan 27.
Although considered exceptional, radiation-induced arteriopathy in long-term breast cancer survivors involves three main arterial domains in the irradiated volume, namely axillary-subclavian, coronary, and carotid. Stenosis of medium-large arteries is caused by "accelerated" atherosclerosis, particularly beyond 10 years after long-forgotten radiotherapy. The present review aims at summarizing what is known about arteriopathy, as well as the state of the art in terms of diagnosis and therapeutic management.
Pauci-symptomatic over years, the usual clinical presentation of arteriopathy involves arm pain with coldness due to subacute or critical ischemia (arterial occlusion), wrongly attributed to an exclusive neurological disorder, and more rarely transient ischemic accident or angina. Evaluation of the supra-aortic trunks by computed tomography and/or magnetic resonance angiography visualizes artery lesions, while Doppler ultrasonography in expert hands assesses diagnosis and downstream functional impact. In severe cases, more invasive angiography directly visualizes long irregular arterial stenosis (full-field radiotherapy), allowing accurate prognosis and treatment.
Requires early diagnosis to enable initiation of medical treatment that increases blood flow (aspirin) as soon as moderate stenosis is detected, combined with correction of vascular risk factors. In intermediate cases, these therapeutic measures are completed by revascularization strategies using transluminal angioplasty-stenting (wall thickness). Antifibrotic treatment is useful in advanced cases with combined radiation injuries.
In follow-up of long-term breast cancer survivors with node irradiation, myocardial infarction is treated even if radiotherapy is forgotten, while recognition and diagnosis of chronic arm ischemia due to subclavian artery stenosis needs to be improved for appropriate therapeutic management.
尽管放射性动脉病被认为是罕见的,但在长期乳腺癌幸存者中,它涉及照射体积内的三个主要动脉区域,即腋窝-锁骨下、冠状动脉和颈动脉。中大型动脉狭窄是由“加速”动脉粥样硬化引起的,尤其是在长期被遗忘的放疗 10 年后。本综述旨在总结关于动脉病的知识,以及在诊断和治疗管理方面的最新进展。
多年来,动脉病的常见临床表现为手臂疼痛伴寒冷,这是由于亚急性或临界性缺血(动脉闭塞)引起的,这被错误地归因于单纯的神经疾病,更罕见的是短暂性脑缺血发作或心绞痛。通过计算机断层扫描和/或磁共振血管造影评估主动脉以上干可显示动脉病变,而专家手中的多普勒超声检查可评估诊断和下游功能影响。在严重的情况下,更具侵入性的血管造影术可直接观察到长而不规则的动脉狭窄(全野放疗),从而准确预测预后和治疗。
需要早期诊断,以便在中度狭窄时就开始使用增加血流量的药物治疗(阿司匹林),并结合纠正血管危险因素。在中等情况下,这些治疗措施通过使用经皮腔内血管成形术-支架置入术(壁厚度)的血管再通策略来完成。在伴有联合放射损伤的晚期病例中,抗纤维化治疗是有用的。
在有淋巴结照射的长期乳腺癌幸存者的随访中,即使放疗被遗忘,也会治疗心肌梗死,而需要提高对锁骨下动脉狭窄引起的慢性手臂缺血的认识和诊断,以进行适当的治疗管理。